| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.4 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.14 | 0.4 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.055 | 0.4 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.13 | 0.4 |